India vs Moldova: Cost drugs extensive resistant tb
India
1,203
in 2024
Moldova
1,400
in 2024
India rank
39th
Moldova rank
36th
Cost drugs extensive resistant tb over time
- India
- Moldova
How they compare
Moldova currently reports 1,400 against 1,203 in India, a difference of 197.
That makes Moldova's figure about 1.2 times India's.
The two have swapped places 3 times across 8 shared years of data; in 2017 it was India ahead.
India ranks 39th and Moldova ranks 36th of 56 countries.
Across the 2 decades both report, India averaged higher in 1 and Moldova in 1.
Head to head by decade
| Decade | India | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7,000 | 5,922 | 1,078 | India |
| 2020s | 2,104 | 2,970 | 866.4 | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cost drugs extensive resistant tb, India or Moldova?
- Moldova, at 1,400 against 1,203 in India as of 2024.
- What is the difference in cost drugs extensive resistant tb between India and Moldova?
- 197, with Moldova ahead.
- How many years of comparable data are there for India and Moldova?
- 8 years are reported by both, from 2017 to 2024.
- How do India and Moldova rank globally for cost drugs extensive resistant tb?
- India ranks 39th and Moldova ranks 36th of 56 countries.
- Where does this data come from?
- Our World in Data, published as Cost drugs extensive resistant tb. Statizoid refreshes it automatically from the source and publishes the full history for both places.